Ceribell is a medical technology company that develops the Ceribell System, a portable point-of-care EEG platform combining disposable headbands and wearables with AI-powered seizure detection algorithms to enable rapid diagnosis and monitoring of seizures in acute care hospital settings. The company addresses a significant clinical need by enabling rapid EEG setup and continuous monitoring within minutes—compared to hours for conventional EEG systems—while reducing reliance on specialized EEG technicians and neurologists through cloud-based remote access and real-time AI analysis. Ceribell generates recurring revenue through sales of disposable wearables and subscription services for its AI algorithm, cloud platform, and hardware, serving over 600 hospitals across the United States and operating with FDA clearances for seizure detection and delirium monitoring.